Poised for growth: life sciences in China
Even in the new economic environment, segments of China’s life sciences industry are poised to grow at double-digit rates. In the midst of this growth, massive changes are underway that could bring even more opportunities to key players, as well as increase efficiency and enhance transparency.
As a result of the investment the government is making in healthcare reform, stakeholders can expect:
- Increased social insurance for healthcare that will lead to more accessible and affordable services
- More efficient and effective delivery of healthcare services
- Increased attention on pricing controls, availability and safety of prescription drugs.
To succeed in China’s rapidly evolving healthcare ecosystem, life sciences organizations will need to focus on innovation, key on manufacturing quality and build effective sales management and channel strategies.
